Pedro Brugarolas

Redox signaling in human pathogens.

Structural and biochemical characterization of N5-carboxyaminoimidazole ribonucleotide synthetase and N5-carboxyaminoimidazole ribonucleotide mutase from Staphylococcus aureus.

Binding of ReO4(-) with an engineered MoO4(2-)-binding protein: towards a new approach in radiopharmaceutical applications.

The oxidation-sensing regulator (MosR) is a new redox dependent transcription factor in Mycobacterium tuberculosis.

Molecular mechanism of quinone signaling mediated through S-quinonization of a YodB family repressor QsrR.

Remyelination therapy goes to trial for multiple sclerosis.

Pharmaceutical integrated stress response enhancement protects oligodendrocytes and provides a potential multiple sclerosis therapeutic.